Treatment of the gout and other forms of crystal-induced arthritis.
D000493:Allopurinol / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy*; D001553:Benzbromarone / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy*; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects; D010653:Phenylbutazone / Q000627:therapeutic use; D011339:Probenecid / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006074:Gout Suppressants; D014527:Uric Acid; D001553:Benzbromarone; D000493:Allopurinol; D010653:Phenylbutazone; D011339:Probenecid; D003078:Colchicine; D013442:Sulfinpyrazone; D007213:Indomethacin